Clinical, demographic and prognostic features of sporadic amyotrophic lateral sclerosis in Northern Turkey

References

• Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet 2007;369(9578):2031–41.
   PubMed Web of Science ®Google Scholar
• Logroscino G, Traynor BJ, Hardiman O, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 2010;81(4):385–903.
   PubMed Web of Science ®Google Scholar
• Lomen-Hoerth C. Amyotrophic lateral sclerosis from bench to bedside. Semin Neurol 2008;28(2):205–11.
   Google Scholar
• Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis 2009;4:3.
   PubMed Web of Science ®Google Scholar
• Borasio GD, Miller RG. Clinical characteristics and management of ALS. Semin Neurol 2001;21(2):155–66.
   PubMed Web of Science ®Google Scholar
• Shook SJ, Pioro EP. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Ann Neurol 2009;65(Suppl 1):S10–6.
   Google Scholar
• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344(22):1688–700.
   PubMed Web of Science ®Google Scholar
• Venizelos AP, Brown HG, Fisher MA. Rapidly fatal neuropathies and an ALS clinical presentation. Acta Neurol Scand 2011;124(4):282–9.
   Google Scholar
• Federici T, Boulis NM. Gene-based treatment of motor neuron diseases. Muscle Nerve 2006;33(3):302–23.
   Google Scholar
• Venkova-Hristova K, Christov A, Kamaluddin Z, Progress in therapy development for amyotrophic lateral sclerosis. Neurol Res Int 2012;2012:187234.
   Google Scholar
• Bedlack RS. Amyotrophic lateral sclerosis: current practice and future treatments. Curr Opin Neurol 2010;23(5):524–9.
   Google Scholar
• Brooks BR, Miller RG, Swash M, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–9.
   PubMed Web of Science ®Google Scholar
• Das K, Nag C, Ghosh M. Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. N Am J Med Sci 2012;4(8):350–5.
   Google Scholar
• Armon C. Smoking may be considered an established risk factor for sporadic ALS. Neurology 2009;73(20):1693–8.
   PubMed Web of Science ®Google Scholar
• de Jong SW, Huisman MH, Sutedja NA, Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study. Am J Epidemiol 2012;176(3):233–9.
   Google Scholar
• Sutedja NA, Veldink JH, Fischer K, Lifetime occupation, education, smoking, and risk of ALS. Neurology 2007;69(15): 1508–14.
   Google Scholar
• Das K, Nag C, Ghosh M. Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. N Am J Med Sci 2012;4(8):350–5.
   Google Scholar
• Sutedja NA, Veldink JH, Fischer K, Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler 2009;10(5–6):302–9.
   PubMed Web of Science ®Google Scholar
• Furby A, Beauvais K, Kolev I, Rural environment and risk factors of amyotrophic lateral sclerosis: a case-control study. J Neurol 2010;257(5):792–8.
   Google Scholar
• Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: prognostic indicators of survival. Amyotroph Lateral Scler 2006;7(4):211–20.
   PubMedGoogle Scholar
• Aroori S, Spence RA. Carpal tunnel syndrome. Ulster Med J 2008;77(1):6–17.
   PubMedGoogle Scholar
• Kiernan MC, Vucic S, Cheah BC, Amyotrophic lateral sclerosis. Lancet 2011;377(9769):942–55.
   Google Scholar
• Chiò A, Logroscino G, Hardiman O, Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10(5–6):310–23.
   PubMed Web of Science ®Google Scholar
• Kihira T, Yoshida S, Okamoto K, Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005. J Neurol Sci 2008;268(1–2):95–101.
   Google Scholar
• Chiò A, Calvo A, Moglia C, Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82(7):740–6.
   PubMed Web of Science ®Google Scholar
• Atsuta N, Watanabe H, Ito M, Research committee on the neurodegenerative diseases of Japan. Age at onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2009;276(1–2):163–9.
   Google Scholar
• Czaplinski A, Yen AA, Simpson EP, Appel SH. Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006;34(6):702–8.
   Google Scholar
• Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006; 253:1428–36.
   PubMed Web of Science ®Google Scholar
• McCombe PA, Henderson RD Effects of gender in amyotrophic lateral sclerosis. Gend Med 2010;7(6):557–70.
   PubMedGoogle Scholar
• Kaufmann P, Levy G, Thompson JL, The ALSFRSr predicts survival time in an ALS clinic population. Neurology 2005;64(1):38–43.
   Google Scholar
• Magnus T, Beck M, Giess R, Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25(5):709–14.
   PubMed Web of Science ®Google Scholar
• Thijs V, Peeters E, Theys P, Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population. Acta Neurol Belg 2000;100(2):84–90.
   PubMed Web of Science ®Google Scholar
• Beghi E, Millul A, Logroscino G, Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2008;9(3):163–7.
   PubMed Web of Science ®Google Scholar
• Ganesalingam J, Stahl D, Wijesekera L, Latent cluster analysis of ALS phenotypes identifies prognostically differing groups. PLoS One 2009;4(9):e7107.
   Google Scholar
• Osamu I., Kano MD, Keisuke Arasaki MD, Ken Ikeda MD, Yasuo Iwasaki MD. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis. Arch Neuro 2007;64(3):458–9.
   Google Scholar
• Blasco H, Guennoc AM, Veyrat-Durebex C, Amyotrophic lateral sclerosis: a hormonal condition? Amyotroph Lateral Scler 2012;13(6):585–8.
   PubMed Web of Science ®Google Scholar
• Cervetto C, Frattaroli D, Maura G, Marcoli M. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2×7 antagonism. Toxicology 2013 Sep; 311: 69–77.
   Google Scholar
• Alves CJ, de Santana LP, dos Santos AJ, Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res 2011;1394:90–104.
   PubMed Web of Science ®Google Scholar
• Bame M, Pentiak PA, Needleman R, Brusilow WS. Effect of sex on lifespan, disease progression, and the response to methionine sulfoximine in the SOD1 G93A mouse model for ALS. Gend Med 2012;9(6):524–35.
   Google Scholar